“…Interestingly, variation of PTPN22 has been recognized as one of the strongest genetic risk factors for autoimmune diseases outside the major histocompatibility complex (MHC) (Burn, Svensson, Sanchez‐Blanco, Saini, & Cope, ). Associations have been reported for rheumatoid arthritis, juvenile idiopathic arthritis, type 1 diabetes mellitus, systemic lupus erythematosus, Graves’ disease, ulcerative colitis and myasthenia gravis (Bottini et al., ; Diaz‐Gallo et al., ; Ferjeni et al., ; López‐Cano et al., ; Orozco et al., ; Orrú et al., ; Remuzgo‐Martínez et al., ; Rodríguez, Alfaro, Balthazar, & Pineda Trujillo, ; Rodriguez‐Rodriguez et al., ; Vandiedonck et al., ; Velaga et al., ), among others. However, besides pemphigus, susceptibility to multiple sclerosis, Addison's disease, inflammatory bowel disease, Crohn's's disease and coeliac disease apparently is not influenced by the PTPN22 polymorphisms (Begovich et al., ; Diaz‐Gallo et al., ; Lee et al., ; Matesanz et al., ; Smyth et al., ).…”